C0-2630. Prospective Grant of Exclusive License: Glycoprotein Hormone Superagonists  

  • [Federal Register Volume 65, Number 30 (Monday, February 14, 2000)]
    [Corrections]
    [Page 7418]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: C0-2630]
    
    
    
    Federal Register / Vol. 65, No. 30 / Monday, February 14, 2000 / 
    Corrections
    
    [[Page 7418]]
    
    
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    National Institutes of Health
    
    
    Prospective Grant of Exclusive License: Glycoprotein Hormone 
    Superagonists
    
    Correction
    
        In notice document 00-2630 beginning on page 5878 in the issue of 
    Monday, February 7, 2000, make the following correction:
        On page 5878, in the third column, in SUMMARY, in the 12th line, 
    ``EndocrinoLogiz, Inc.'' should read ``EndocrinoLogix, Inc.''.
    
    [FR Doc. C0-2630 Filed 2-11-00; 8:45 am]
    BILLING CODE 1505-01-D
    
    
    

Document Information

Published:
02/14/2000
Department:
National Institutes of Health
Entry Type:
Correction
Document Number:
C0-2630
Pages:
7418-7418 (1 pages)
PDF File:
c0-2630.pdf